SHZ · 000538.SZ
Yunnan Baiyao Group Co.,Ltd
CN¥53.73+CN¥0.80 (+1.51%)
Yunnan Baiyao Group Co.,Ltd’s quoted price sits in the upper half of its reported 52-week range, 7.68% below the high.
Loading market information…
SHZ · 300146.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:16 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
By-health Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
By-health Co., Ltd.’s forward annual dividend is CN¥0.45 per share, paid annual. The forward yield is 4.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
By-health Co., Ltd.’s next earnings report is currently expected on Mar 22, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow By-health Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
By-health Co., Ltd. operates internationally as a producer and vendor of a diverse range of dietary supplements. Its comprehensive portfolio encompasses essential nutrients like proteins, vitamins, and minerals, in addition to specialized solutions addressing numerous health needs. These include offerings for supporting bone and joint integrity, promoting cardiovascular and brain health, enhancing beauty, boosting immunity, assisting with weight control, improving vigor, nourishing eyes, aiding sleep, managing blood sugar, optimizing memory, and supporting reproductive wellness. The company also provides tailored nutrition for children, expectant mothers, and the well-being of the liver, digestive tract, and stomach. Sold under the "By-health" and "GymMax" labels, these products are designed for all age groups—children, adult men and women, and seniors—and are distributed globally through a multi-channel approach involving wholesale partners, retail stores, and online platforms. Established in 1995, By-health Co., Ltd. is based in Guangzhou, China. The firm was previously known as Guangdong By-Health Biotechnology Co., Ltd. until its rebranding in April 2012.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥0.27 |
| CN¥1.79B |
| Q4 2024 | Mar 21, 2025 | -CN¥0.13 | CN¥1.10B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥53.73+CN¥0.80 (+1.51%)
Yunnan Baiyao Group Co.,Ltd’s quoted price sits in the upper half of its reported 52-week range, 7.68% below the high.
CN¥17.74+CN¥0.29 (+1.66%)
Xiamen Kingdomway Group Company’s quoted price sits in the upper half of its reported 52-week range, 17.57% below the high.
CN¥4.22+CN¥0.05 (+1.2%)
Zhejiang CONBA Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.38% below the high.
CN¥10.63+CN¥0.02 (+0.19%)
Zhejiang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.84% below the high.
CN¥4.36+CN¥0.03 (+0.69%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
CN¥9.93+CN¥0.90 (+9.97%)
Haoxiangni Health Food Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.07% below the high.
CN¥3.71+CN¥0.08 (+2.2%)
Shanghai Jiaoda Onlly Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.01% below the high.
CN¥9.62-CN¥0.09 (-0.93%)
Shanghai No.1 Pharmacy Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.14% below the high.
